Secondary analysis of renal end points in a cardiovascular safety trial of a DPP-4 inhibitor in patients with T2DM at high cardiovascular risk, showing that saxagliptin reduces albuminuria in a glucose-independent manner
GLP-1 receptor agonists work through a different mechanism than thyroid hormone replacement
Secondary dysautonomias are experienced because of another disease process, as in autonomic neuropathy associated with diabetes or POTS resulting from an autoimmune disease
Abstract Background Idiopathic intracranial hypertension (IIH) is a neurological condition marked by elevated intracranial pressure (ICP) with no evident secondary cause, primarily affecting obese females of childbearing age
Husk at verifisering (KYC) ikke er et hinder for deg, men et vern mot misbruk av identitet og konomi
Starting at three months also gives your provider time to screen for postpartum thyroid dysfunction , which affects up to 10 percent of new mothers and can cause weight retention that GLP-1 medications will not fully address
